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Background: Patient-controlled analgesia (PCA) administration of opioids is associated with risk for respiratory depression. Capnography is a non-invasive way to identify early respiratory 
depression and prevent adverse patient events. 
Purpose: This project evaluated the effectiveness of capnography versus standard monitoring in reducing adverse events among patients admitted to an intensive care unit (ICU) who were 
prescribed PCA opioids and evaluated patients at high-risk for respiratory depression according to age, gender, diagnosis, co-morbidities, and type of opioid prescribed.
Methods: This project used a pre- and post-intervention design to compare differences in the number of adverse events among 20 adult patients admitted to an ICU during a six-month period 
who were prescribed PCA opioids and received either capnography monitoring or standard monitoring.  A chi-square test was conducted to evaluate group differences.
Results: The number of adverse events was not significantly different between patients who received standard monitoring versus those who received capnography (X2=0.00, df=1, N=20, 
p>0.05). Adverse events were not significantly associated with age, gender, number of co-morbidities, type of opioid, and diagnosis (p>0.05).
Conclusions: Implementation of capnography among ICU patients on PCAs did not prevent adverse events. However, there were favorable trends noted with regards to sedation level and a 
decrease in the occurrence of bradypnea in patients receiving capnography.  Results from this project will guide the implementation of capnography throughout the institution. 
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Conclusions:
• There was no statistically significant difference in the number of 
adverse events for patients receiving capnography versus 
standard monitoring.
• Although not statistically significant, patients older than 55 
years of age, females, those receiving epidural patient-
controlled analgesia, and those with two or more co-morbidities 
plus a history of lung or cardiac disease, obstructive sleep 
apnea, or greater than a 20-pack year history of smoking, had 
more observable adverse events. 
• Implementing capnography monitoring among patients with 
these risk factors may allow for earlier intervention.
• Limitations with this project included the small sample size, ICU 
setting in which this project was implemented, eligibility criteria 
and issues with the nasal cannula equipment. 
Recommendations:
• Although capnography monitoring had no impact on prevention 
of adverse events, patients with certain characteristics can 
benefit from capnography monitoring. 
• Future directions with capnography monitoring include further 
defining patients who would profit from capnography, 
determining added equipment purchases, and development of 
nursing education and medical policies so that capnography is a 
part of  standardized practice. 
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Objectives for this project included:
1. Decrease adverse respiratory events in adult high-risk patients in the ICU who receive PCAs or narcotic to less than 
one (< 1) during the 3-month period after implementation of capnography by December 2020 .
2. Analyze project results to define high risk patient characteristics when capnography implemented on patient care 
units outside of the ICU. 
3. . Analyze data and use project findings to inform the development of policies and procedures for capnography 
monitoring for patients on PCAs or receiving narcotics by January 2021 . 
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Design: This evidenced based practice project implemented a 
pre- and post-intervention design.
Setting and Participants:  
• The setting for this project was an ICU.
• Participants were adult patients (18 years or older) 
prescribed epidural or intravenous (IV) PCAs or high doses 
of opioids, not on PCAs. 
• Critically ill patients and those receiving end of life care 
were excluded. 
Methods:  
• A retrospective chart review during a three-month period 
(June through August 2020) of 10 eligible ICU patients who 
received standard monitoring was conducted.  The number 
and type of adverse events was measured for these 
patients.  
• Capnography monitoring was then implemented for a 
three-month period (September-December 2020) for 10 
patients. Adverse events were tracked for these patients.  
Analysis: 
• The comparison of capnography monitoring versus standard 
monitoring to prevent adverse events was analyzed using 
Chi-square test of independence were p <.05.  
• Adverse events associated with age, gender, diagnosis, 
number of co-morbidities, and type of opioid was also 
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